Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial
Conclusions
Among maintenance dialysis patients with hypertension and left ventricular hypertrophy, atenolol-based antihypertensive therapy may be superior to lisinopril-based therapy in preventing cardiovascular morbidity and all-cause hospitalizations. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases; ClinicalTrials.gov number: NCT00582114)
Source: Nephrology Dialysis Transplantation - Category: Urology & Nephrology Authors: Agarwal, R., Sinha, A. D., Pappas, M. K., Abraham, T. N., Tegegne, G. G. Tags: Intra- and Extracorporeal Treatments of Kidney Failure Source Type: research
More News: Atenolol | Beta-Blockers | Cardiology | Cardiovascular | Diabetes | Dialysis | Endocrinology | Heart | Heart Attack | Heart Failure | Heart Transplant | Hemodialysis | Hypertension | Kidney Transplant | Kidney Transplantation | Lisinopril | Stroke | Study | Transplants | Urology & Nephrology